Esomeprazole for autistic disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Mar 2019: Trial registered, NCT03866668
  2. 29 May 2019: Trial started, NCT03866668

The trials

NCT03866668: A Study of Esomeprazole in Children With Autism

State
Under way
Phase
Phase 2
People
25 planned
Started
29 May 2019
Primary completion
Dec 2028
Arms
Esomeprazole
Results
None posted
  1. 7 Mar 2019: Trial registered
  2. 29 May 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Inexium paranova.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.